The independent source for health policy research, polling, and news.
The Good and Bad of Those Ubiquitous Drug Ads
In this column for The Wall Street Journal’s Think Tank, Drew Altman examines the public’s mixed views about prescription drug ads and their impact on prescribing patterns, based on a new survey.
Column Read PostLessons Learned from Eight Years of Supporting Institutional to Community Transitions Through Medicaid’s Money Follows the Person Demonstration
Since 2008, the Kaiser Family Foundation’s Commission on Medicaid and the Uninsured has periodically surveyed state Money Follows the Person (MFP) programs, conducted state case studies, and profiled the experiences of individual MFP beneficiaries. Based on the information and data collected in our six surveys, we identify some lessons learned from MFP that could inform future Medicaid long-term services and supports rebalancing policies.
Read PostCovering the Remaining Uninsured: Not Just a Red-State Issue
In this column for The Wall Street Journal’s Think Tank, Drew Altman explains why covering the nation’s remaining uninsured population is more than just a red state issue.
Column Read PostJAMA Forum: Why the Ruckus Over the Cadillac Plan Tax?
Larry Levitt’s October 2015 post explains the terms of the much-debated Cadillac plan tax, how it is designed to reduce health costs, and how it could end up shifting more costs to workers.
Read PostTwo Substantive Sides to Debate Over Obamacare’s ‘Cadillac Tax’
In this column for The Wall Street Journal’s Think Tank, Drew Altman says debate about whether to keep or repeal the Cadillac tax is more than a debate between sound policy and good politics, there are strong substantive arguments on both sides.
Column Read PostWhy Consumer Issues Are Rising on the Health Agenda
In this column for The Wall Street Journal’s Think Tank, Drew Altman examines the trends that may be leading to a rise in consumer cost issues on the health agenda.
Column Read Post